Right Molecule, Right Isotope, Right Target: Engineering Smarter Radioligands

  • Importance of isotope and chelator choice for binding, stability, and pharmacokinetics
  • AI-driven in silico screening of isotopes, chelators, linkers and ligands
  • Matching isotopes and chelators to radioligands PK, efficacy, and safety profiles